Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Inhibitors of JNK, compositions and methods of use described by Vertex team

Jan. 30, 2001

New heterocyclic chemopreventive agents described in U.S. patent

Jan. 30, 2001

Cel-Sci/NCI CRADA renewed and expanded

Jan. 30, 2001

Enrollment begins in phase III trial of Leuprogel 4-month for prostate cancer

Jan. 30, 2001

Production, development of recombinant mammastatin planned by Biotherapies

Jan. 30, 2001

Oxford BioMedica and AHP jointly develop novel antibody cancer therapy

Jan. 30, 2001

PBOX-6 shows potential for bypassing apoptotic suppressor Bcr-Abl in CML

Jan. 30, 2001

Geron regains rights to telomerase inhibitors from Pharmacia; forms new division

Jan. 30, 2001

Somatostatin and neuromedin B receptor agonists and their use

Jan. 29, 2001

New isocoumarins with antiangiogenic activity claimed by Korean scientists

Jan. 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...